
Pharmaceuticals Drive Indian Firms to Record $20.5 Billion Investment in US During SelectUSA Summit
Record $20.5 Billion in Investments from Indian Companies Announced at SelectUSA Investment Summit
The 2026 SelectUSA Investment Summit in Maryland, near Washington, DC, has witnessed a record $20.5 billion in investments from leading Indian companies. These investment commitments span major sectors such as pharmaceuticals, advanced manufacturing, energy infrastructure, and emerging technologies. Officials expect these investments to generate thousands of jobs in both countries while expanding US production capacity and fostering joint innovation.
The investment commitments are expected to drive growth in various sectors, with a significant share coming from India's pharmaceutical sector. This sector accounts for more than $19.1 billion in planned spending across US manufacturing, research and development, and new facilities. Additional investments in steel, connectivity, and energy supply chains are expected to strengthen critical US industrial capacity and enhance supply chain resilience.
Sun Pharmaceutical Industries Ltd is spearheading the investment commitments, planning a $11.75 billion acquisition of New Jersey-based Organon & Co. Other major pharmaceutical companies such as Aurobindo Pharma Ltd, Biocon Group, Cipla Limited, Dr Reddy's Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Granules India Ltd, Jubilant Group, Lupin Limited, Piramal Pharma Ltd., and Zydus Lifesciences Limited are also contributing to this growth.
Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
In addition to the pharmaceutical sector, 12 Indian companies announced over $1.1 billion in new greenfield and expansion projects across multiple US states, supporting jobs in manufacturing, technology, and engineering. These announcements exceed the cumulative total of all prior SelectUSA Investment Summit commitments from India and represent the largest contribution by any country at this year's summit.
| Sector | Investment Amount |
|---|---|
| Pharmaceuticals | $19.1 billion |
| Steel | $ |
| Connectivity | $ |
| Energy Supply Chains | $ |
The developments highlight the role of the SelectUSA Investment Summit in connecting global investors with opportunities across the United States, while demonstrating how international investment continues to drive economic growth, innovation, and workforce development. The SelectUSA Investment Summit is the premier US platform for facilitating business investment, bringing together thousands of investors, companies, economic development organizations, and industry experts to forge partnerships and explore growth opportunities.
Investor Takeaway
Investors should consider the growing opportunities in the US-India bilateral trade and the potential for significant investments in the pharmaceutical sector.
More in Economy

Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

MoSPI Releases Uniform Norms for DDP Estimates with 2022-23 Base Year
